The commitment to is manifested in our drive to develop novel Active Pharmaceutical Ingredients (APIs) efficiently and .
Our chemistry enhances our capability to establish sustainable manufacturing processes, further solidifying our position .
Within the of pharmaceutical development, Aurobindo Research Centre stands as a beacon of ingenuity, propelling of our organization through a relentless .
Our focus on product development has led to in various therapeutic areas, positioning us at the forefront of pharmaceutical industry.
Our focus on biosimilars, vaccines, and generic formulations underscores our commitment to develop solutions which ensure the best outcomes for the patient.
Our R&D efforts are aimed towards developing biosimilars, vaccines, generic APIs, generic formulations including orals, injectables, complex products like inhalers, nasal sprays, depot injections and transdermal patches.
Our strategic partnerships with esteemed academic institutions like NIPER, JNTU, and IITs enable us to access cutting-edge research, specialised knowledge, and state-of-the-art facilities, fostering a culture of excellence.
Additionally, our collaboration with technology companies empowers us to harness advanced digital technologies such as artificial intelligence and machine learning, revolutionising our R&D capabilities and enhancing our ability to develop novel pharmaceutical solutions.
Through these synergistic partnerships, we remain committed to pushing the boundaries of scientific discovery, delivering breakthrough therapies, and advancing global healthcare.
In our quest for operational excellence, we have embarked on a journey of digital transformation to streamline processes, enhance collaboration, and drive greater efficiency across the organization.
Through the adoption of digital technologies and advanced software solutions, we are optimizing our workflows, improving communication and collaboration among teams, and empowering our employees to work more effectively and efficiently.
This strategic focus on digital transformation not only enhances our internal operations but also positions us for future growth and success in an increasingly competitive market landscape.
* FY24 R&D Expenditure
© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.